Rapiscan Injection
Regadenoson
0.4mg/5ml
GE HEALTHCARE AS
| Pack size | 1 Glass Vial (5ml) |
|---|---|
| Dispensing mode | POM |
| Source | NORWAY |
| Agent | AL ZAHRAWI MEDICINES TRADING |
| Retail Price | 348.50 AED |
Indications
Rapiscan Injection is used for:
Diagnostic agent for radionuclide myocardial perfusion imaging (MPI)
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Regadenoson :
Mechanism of Action
Regadenoson is an selective low-affinity (Ki= 1.3 ˵M) A2A receptor agonist that mimics the effects of adenosine in causing coronary vasodilatation and increasing myocardial blood flow. It is a very weak agonist of the A1 adenosine receptor (Ki > 16.5 ˵M). Furthermore, it has negligible affinity to A2B and A3 adenosine receptors. Regadenoson is undergoing trials for use in pharmacological stress tests. Adenosine slows conduction time through the A-V node, can interrupt the reentry pathways through the A-V node, and can restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT), including PSVT associated with Wolff-Parkinson-White Syndrome.
Note
Rapiscan 0.4mg/5ml Injection manufactured by GE HEALTHCARE AS. Its generic name is Regadenoson. Rapiscan is availble in United Arab Emirates.
Farmaco UAE drug index information on Rapiscan Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.